身体炼对刺激性肠综合征微生物群的影响
Chunpeng Li1, Jianmin Li2, Qiaorui Zhou3
1Russian Sports University, Moscow 105122, Russia.
Nutrients
|August 29, 2024
概括
身体炼,特别是有氧活动,可以改善肠道微生物群的多样性,并减少刺激性肠综合征 (IBS) 患者的症状. 量身定制的练习计划是有效管理IBS的关键.
科学领域:
- 胃肠病学 胃肠病学
- 微生物学 微生物学
- 运动科学 运动科学
背景情况:
- 刺激性肠综合征 (IBS) 是一种常见的功能性胃肠疾病,与肠道微生物群失衡有关.
- 肠道微生物群在IBS的发病过程中起着至关重要的作用,影响腹痛和胀气等症状.
研究的目的:
- 审查体育炼对IBS患者肠道微生物群的影响.
- 探索运动如何调节肠道细菌并减轻IBS症状.
- 讨论个性化炼协议对IBS管理的重要性.
主要方法:
- 关于有氧运动 (跑步,游泳,骑自行车) 和其对IBS肠道微生物群的影响的研究综述.
- 对肠-大脑轴和运动对IBS精神健康的影响的研究分析.
- 检查受运动影响的有益细菌产生的短链脂肪酸 (SCFA).
主要成果:
- 有氧运动可以增强有益的肠道细菌 (乳杆菌,Bifidobacterium),增加SCFA的产生,减少炎症.
- 在IBS患者中,结构化的运动计划显示了肠道微生物群组成和多样性的显著改善.
- 运动对心理健康产生积极影响,减少压力和改善情绪,从而有助于缓解IBS症状.
结论:
- 身体炼是IBS的一种有前途的非药物干预措施,它调节肠道微生物群并改善症状.
- 推个性化炼计划,从中等强度开始,以最大限度地提高效益并最大限度地降低风险.
- 需要进一步研究更大的样本大小和更长的随访,以优化IBS管理的炼协议.
更多相关视频
相关概念视频
01:17Irritable Bowel Syndrome I: Introduction
263
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
263
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
187
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
187
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
152
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
152
01:29Bacterial Flora of the Large Intestine
400
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
400
01:17Drugs for Treatment of Diarrhea-Predominant IBS
153
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
153
01:21Drugs for Treatment of Constipation-Predominant IBS
146
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
146